Polyp Biopsy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Polyp Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The liquid biopsy market size is projected to reach US$ 8,123.85 million by 2027 from US$ 3,861.49 million in 2019. The liquid biopsy market CAGR is estimated to grow at 9.9% from 2020 to 2027.
Surge in number of cancer patients and rise in preference for minimally invasive procedures are some key factors driving liquid biopsy market revenue growth
The global aspiration & biopsy needles market size was USD 875.3 Million in 2021 and is expected to register a revenue CAGR of 6.8% during the forecast period, according to latest analysis by Emergen Research. Rising prevalence of cancer cases owing to various lifestyle changes, rapid urbanization and rising pollution levels, and changing consumption habits and increasing cancer awareness programs and screening and tests by governments and various global health organizations are some of the key factors driving global aspiration and biopsy needles market revenue growth. According to World Cancer Research Fund International, around 18,094,716 million cases of cancer were diagnosed in 2020.
According to Renub Research analysis China Biopsy Market will be USD 8.1 Billion by 2026. Forecast by Cancer Segment, Volume of Biopsy and Patient Diagnosed Numbers, Company Analysis. Follow the Link for More Information: https://www.renub.com/china-biopsy-market-p.php
The blood cancer detection market is expected to continue to grow in the coming years, driven by the factors mentioned above. The development of new and improved diagnostic technologies, such as liquid biopsy, is expected to further drive the growth of the market. Liquid biopsy is a minimally invasive technique that can be used to detect blood cancer by analyzing cell-free DNA circulating in the blood.
According to the latest research report by IMARC Group, The global liquid biopsy market size reached US$ 1.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 15.3% during 2023-2028. More Info:- https://www.imarcgroup.com/liquid-biopsy-market
The growth of the studied market is driven due to the rising incidence of oncology diseases, the need for efficient prognosis and early diagnosis of various forms of cancer, and rising initiatives by key players in the development of innovative solutions to meet the increasing demand for efficient diagnostics. Several tests, including physical examination, laboratory tests, imaging tests, and biopsies have traditionally been performed in cancer diagnosis. Each step of the usual diagnostic procedure with the prognosis and therapeutic decision made by oncologists comes with a well-defined diagnosis to avoid potential complications. This highlights the crucial importance of diagnosis throughout the entire oncology lifecycle, surpassing the therapeutic regime's significance.
Liquid Biopsy Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product & Services (Equipment, Reagents & Kits, and Services), Sample (Blood Based, Urine Based, and Other Samples), Circulating Biomarker [Circulating Tumor Cells (CTC), Exosomes, and Free Nucleic Acid], Application [Noninvasive Prenatal Testing (NIPT), Oncology, Transplant Diagnostics, and Other Applications], and End User (Academic & Research Institutes, Hospitals, Reference Laboratories, and Other End Users)
Market Size – USD 904.5 Million in 2021, Market Growth – at a CAGR of 7.0%, Market Trends – Growing Research & Development (R&D) activities in the North America region
Liquid biopsy reduces the apprehension of patients regarding pain and provides a safe and effective method of diagnosis. As a result, there has been increasing demand for a non-invasive alternative, such as liquid biopsy, over tissue biopsy that involves the painful extraction of diseased tissue, which is fueling the market growth. Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: Visit the following link: https://www.imarcgroup.com/liquid-biopsy-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
The liquid biopsy market size is projected to reach US$ 8,123.85 million by 2027 from US$ 3,861.49 million in 2019. The liquid biopsy market CAGR is estimated to grow at 9.9% from 2020 to 2027.
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027.
The Asia Pacific cancer screening market is estimated to garner a revenue of USD 142542.43 Million by the end of 2030, by growing at a CAGR of 13.37% over the forecast period, i.e., 2021 – 2030.
The needle biopsy market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.2% in the forecast period of 2021 to 2028 and is expected to reach USD 154.18 million by 2028.
The Prostate Cancer Diagnostics Market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.
The needle biopsy market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.2% in the forecast period of 2021 to 2028 and is expected to reach USD 154.18 million by 2028.
Cancer Diagnostics Global Market Report 2020 is the latest research report added to The Business Research Company database. The report is covered in 200 pages covering 5 major players in the industry.
The Asia Pacific cancer screening market is estimated to garner a revenue of USD 142542.43 Million by the end of 2030, by growing at a CAGR of 13.37% over the forecast period, i.e., 2021 – 2030.
The growing incidence of cardiovascular diseases and the technological developments in interventional cardiology devices are driving the demand of the market.
Increasing popularity of touchable holographic displays and rising investments in holographic technology by major industry participants are driving holographic imaging market revenue growth
The reprocessed medical devices market is projected to reach US$ 5,653.87 million by 2028 from US$ 2,087.36 million in 2021; it is expected to grow at a CAGR of 15.3% from 2021 to 2028.
Stay up-to-date with latest Insights of Dermatology Devices market research offered by Allied Market Research. Check how key trends and emerging drivers are shaping this industry growth.
According to The Insight Partners market research study titled Helicobacter Pylori Non-Invasive Testing Market to 2027 – Global Analysis and Forecasts by Test Type, Test Method, End User and Geography. The Global Helicobacter Pylori Non-Invasive Testing Market is expected to reach US$ 768.23 Mn in 2027 from US$ 539.70 Mn in 2018. The market is estimated to grow with a CAGR of 4.1% from 2019-2027. The report highlights the trends prevalent in the global Helicobacter pylori non-invasive testing market and the factors driving the market along with those that act as challenges to its growth.
The increasing prevalence of the disease represents one of the significant factors strengthening the biopsy devices market growth. Apart from this, the increasing awareness among individuals about the availability of diagnostic and screening procedures for chronic diseases is positively influencing the demand for integrated technologies, such as stereotactic-guided biopsies. For more information, request for a free sample report here: https://www.imarcgroup.com/biopsy-devices-market/requestsample
Looking forward, the biopsy devices market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/biopsy-devices-market
Plastic Surgery & Integumentary System Procedures market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Plastic Surgery & Integumentary System Procedures market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Procedure and by Application in terms of revenue and forecast for the period 2015-2026.
The growing prevalence of infectious diseases and high prevalence is a major factor driving the growth of the global infectious disease market. In addition, technological advances in diagnostic instruments, the government's initiative to develop appropriate healthcare infrastructure in emerging economies, and a greater understanding of diagnosis in developed economies will enhance the development of the global infectious disease diagnostics..
“Brazil General Surgery Market Outlook to 2020", provides key market data on the Brazil General Surgery devices market. The report provides value, in millions of US dollars, and volume (in units) within market categories - Bronchoscopes, Laryngoscopes, Ureteroscopes, Cystoscopes, Colonoscopes, Sigmoidoscopes, Esophagoscopes & Gastroscopes, Duodenoscopes, Laparoscopes, Hysteroscopes, Sinuscopes, Resectoscopes, Endoscopy Visualization Systems, Endoscopy Visualization System Components, Endoscopic Reprocessors, Endoscopy Fluid Management Systems, Capsule Endoscopy Systems, Surgical Generators, Bariatric Surgery Devices, Aesthetic Lasers and Energy Devices, Biopsy Devices, Hernia Repair, Non-Vascular Stents and Gynecological Devices. See Full Report : http://bit.ly/1D9eKix
The growth is mainly led by product and technological innovations, increasing incidence of breast cancer cases, rising propensity for minimally invasive surgeries, and mounting number of breast cancer screening programs.
Increasing cancer prevalence, preference for non-invasive diagnostics techniques and shift towards personalized medicines are the key factors driving the global liquid biopsy market.
First China, the country where the virus originated, and then other countries incrementally saw R&D investment into Coronavirus diagnostics and treatment overtake R&D investment into cancer. Going by this bare fact, it would appear that the demand for liquid biopsy technology would drop. However, this was not the case and sales of liquid biopsy products actually grew faster in 2020 than nearly all earlier estimates.
According to the Regional Research Reports, The Global Breast Biopsy Market is projected to reach USD 2.15 billion by 2030 from USD 745.50 million in 2021, growing at a CAGR of 8.60% from 2022 to 2030. Request For Report Description @ https://www.regionalresearchreports.com/industry-reports/breast-biopsy-market/HC-1385
Global Cancer Diagnostics Market is forecasted to grow at a CAGR of 8.8% during 2016 – 2021F, on account of rising incidences of cancer globally, along with the increasing technological advancement driven by focus on cancer research.
According to the latest research report by IMARC Group, The global idiopathic pulmonary fibrosis treatment market size reached US$ 3,848.3 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 6,980.4 Million by 2032, exhibiting a growth rate (CAGR) of 6.6% during 2024-2032. More Info:- https://www.imarcgroup.com/idiopathic-pulmonary-fibrosis-treatment-market
Anatomic Pathology Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2015-2022 The Global anatomic pathology market is expected to grow at a CAGR of 6.8 % during 2017-2022. The branch of medicine that studies the effect of disease on the structure of body organs, both as a whole (grossly) and microscopically is known as Anatomic (or anatomical) pathology.
The global computed tomography (CT) scanners market is growing at a CAGR of 5.26% and is likely to reach $12587.31 million, during the forecast period 2023-2032
The Breast Biopsy Devices Market size was valued at US$ XX Mn in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 10.9% for the forecast period ending 2023 reaching a Market value of US$ XX Mn.
The global interventional pulmonology market size was USD 1.36 Billion in 2022 and is expected to reach USD 2.31 Billion by 2032, and register a rapid revenue CAGR of 5.3% during the forecast period. Rising prevalence of respiratory illnesses and demand for minimally invasive procedures and developments in interventional pulmonology technology are major factors driving market revenue growth.
According to the latest research report by IMARC Group, The global onychomycosis treatment market size reached US$ 3.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.37% during 2023-2028. More Info:- https://www.imarcgroup.com/onychomycosis-treatment-market
The global automated blood collection market size was USD 1.08 Billion in 2021 and is expected to register a revenue CAGR of 7.1% during the forecast period, according to latest analysis by Emergen Research. Market revenue growth is primarily driven by factors such as growing public awareness about advantages that automated blood collection methods offer over manual blood collection techniques, ongoing demand for blood in hospitals, nursing homes, and ambulatory care facilities, rising rates of traffic accidents and trauma cases globally, and rising surgical rates.
The Global Special Purpose Needles Market was valued at US$ 10.44 billion in 2021 and is predictable to reach US$ 22.01 billion by 2030 which is projected to attain a CAGR of 8.6 % during the forecast period from 2021- 2030. Needles are referred as a device made up of metal, glass, or rubber tubes used for delivering drugs and collecting fluids from the body.
The global liver disease management market size reached USD 22.05 Billion in 2021 and is expected to register a revenue CAGR of 5.6% during the forecast period, according to latest analysis by Emergen Research. Rising demand for liver disease management in various imaging applications for industrial and manufacturing purposes in addition to increasing alcohol consumption are some of the factors driving market revenue growth. Companies are launching pipeline drugs, and ongoing clinical trials by several industries are also driving the market revenue growth of liver disease management.
Electron microscope is an electronic device that is used to observe tiny organisms or particles which are difficult to see with naked eyes. The electron microscope is used in various end user industries for its applications. The Electron Microscopy Market deals with the demand and supply, production and scope of innovation in electron microscopy technology during 2015-2020.
According to our new research study on "Skin Cancer Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, and Screening Type," the skin cancer diagnostics market size is expected to reach US$ 5,480.45 million by 2028 from US$ 3,364.46 million in 2021; it is estimated to grow at a CAGR of 7.2% from 2021 to 2028. The report highlights trends prevailing in the skin cancer diagnostics market and factors governing its growth. The increasing incidence of skin cancer and launch of new product are driving the growth of the market. However, barriers to early skin cancer diagnostics in low and middle-income countries hinders the skin cancer diagnostics market growth.
The Asian orthobiologics market is segmented and forecasted based on products and end users. Based on geography, the market has been segmented into Japan, China, India, Republic of Korea, and the Rest of Asia. This report also includes the market share, value chain analyses, and market metrics such as drivers, restraints, and upcoming opportunities.